🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Paula A. Lengerke-Diaz

Mayo Clinic in Arizona

ORCID: 0000-0002-1285-8499

Also affiliated with Mayo Clinic Hospital

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Ibrutinib plus Obinutuzumab as Frontline Therapy for Chronic Lymphocytic Leukemia Is Associated with a Lower Rate of Infusion-Related Reactions and with Sustained Remissions after Ibrutinib Discontinuation: A Single-Arm, Open-Label, Phase 1b/2 Clinical Trial NCT0231576”.

Ibrutinib plus Obinutuzumab as Frontline Therapy for Chronic Lymphocytic Leukemia Is Associated with a Lower Rate of Infusion-Related Reactions and with Sustained Remissions after Ibrutinib Discontinuation: A Single-Arm, Open-Label, Phase 1b/2 Clinical Trial NCT0231576

Advances in Hematology(2022)10.1155/2022/4450824
N/A
0.308DataRank · unranked
3 citations

Paula A. Lengerke-Diaz, Juliana Vélez Luján, Michael Y. Choi, Eider Moreno-Cortes, José Vicente Forero-Forero +7 more

Smartphone based on-chip fluorescence imaging and capillary flow velocity measurement for detecting ROR1+ cancer cells from buffy coat blood samples on dual-layer paper microfluidic chip

Biosensors and Bioelectronics(2020)10.1016/j.bios.2020.112042
N/A
0DataRank · unranked
49 citations

Ryan Zenhausern, Alana Gonzales, David Knoff, Paula A. Lengerke-Diaz, Januario E. Castro +2 more

Ibrutinib plus obinutuzumab as frontline therapy for chronic lymphocytic leukemia is associated with a lower rate of infusion-related reactions and with sustained remissions after ibrutinib discontinuation: a single-arm, open-label, phase 1b/2 clinical trial NCT0231576

Research Square(2021)10.21203/rs.3.rs-887972/v1
N/A
0DataRank · unranked
0 citations

Paula A. Lengerke-Diaz, Juliana Velez-Lujan, Michale Y. Choi, Eider Moreno-Cortes, José Vicente Forero-Forero +7 more

Dysregulated Spliceosome Activity Involves Increased Intron Retention Plus Upregulation and Phosphorylation of SF3B1 in Chronic Lymphocytic Leukemia

Research Square(2022)10.21203/rs.3.rs-1622375/v1
N/A
0DataRank · unranked
0 citations

Hiren Karathia, Deepak Kumar, Roberto Vera Alvarez, Paula A. Lengerke-Diaz, José Vicente Forero-Forero +15 more

Aberrant spliceosome activity via elevated intron retention and upregulation and phosphorylation of SF3B1 in chronic lymphocytic leukemia

Molecular Therapy — Nucleic Acids(2024)10.1016/j.omtn.2024.102202
N/A
0DataRank · unranked
3 citations

Hiren Karathia, Deepak Kumar, Roberto Vera Alvarez, Jose Vicente Forero-Forero, Eider Moreno +15 more